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PRESIDENTIAL ADDRESSSome thoughts from the other side of the table, or the last presidential
addressNorman E. Shumway, Jr, MD, PhDyI am just as surprised to be standing here today as you are to
see me here. I just hope I will not become dumbstruck like
the man who had both deja vu and amnesia at the same time.
Two years ago when the association met in New Orleans
and Herb Sloan called to tell me I was to be the vice presi-
dent, I had no idea that it was tantamount to being president-
elect. I thought it was like being a vice president of the
American College of Surgeons or, perhaps even worse,
Vice President of the United States. My confusion was com-
pounded further by the fact none of my training was at the
Johns Hopkins. This seemed almost always a prerequisite
for the office. At any rate, it is a qualified pleasure to
have this opportunity to reflect on three decades of experi-
ence in surgery of the heart. There have been some really
great moments and some far from great. You will not be ex-
posed in these comments to all of my prejudices but very
definitely to some. First off, with apologies to Paul Ebert
and his successors, the so-called presidential address should
be abandoned. It is usually a summary of material already
published and sometimes reveals more than we ever want
to know about the incumbent. You will soon appreciate
why this should be the last presidential address. It very def-
initely will be my last. Actually, at least two additional
scientific papers could be accepted for presentation if this
tradition were terminated.
Since I have no way of eluding responsibility for this
year’s meeting, I hope you will be interested in hearing
some thoughts that have come to one of the world’s great
first assistants whose pleasure it has been to watch the
growth and development of a talented group of colleagues.
Like so many of you, I have spent considerable time across
the table from young surgeons who were developing their
clinical skills, giving me time to consider the so-called
larger picture.
Mostof youknowbynow that themostdifficult thing about
surgery—even heart surgery—is getting a chance to do it. In-
the early days at the University ofMinnesota not only did the
chief resident on the heart service not operate, he did notyDeceased.
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ebrated chief of surgery—split the cardiovascular surgical
service so that two full professors were not helping each
other do the operations. I resolved then never to indulge
in this kind of so-called residency training if the
opportunity presented to do otherwise. Certainly it cannot
matter as much who does the operation, as how it is done.
The day of the super surgical technician has been greatly
exaggerated. Some of you, exposed to more general sur-
gery than I, will recall the immortal words of Sir Heneage
Ogilviewho said, ‘‘when the incomparable surgical techni-
cian meets the impossible deodenum, the duodenum wins
every time.’’ Sir Heneage also remarked with respect to
the great surgeon who can always get out of trouble that
he would much rather fly across the Atlantic with a pilot
who never had difficulty than with one who was an expert
at landing on icebergs.
In 1972, several of us were fortunate enough to attend the
dedication banquet for that first of a long line of heart insti-
tutes around every corner. Wherever there’s a cardiologist
with a balloon catheter there has to be a heart institute. At
any rate, the head table that night in Houston was actually
double-decked to accommodate the many after-dinner
speakers. Finally, it came my turn to offer a few remarks,
and it looked like a good chance to emphasize the point
that how is more important than who. So, I stated that we
all congratulated and envied Dr Cooley for his new institute.
We in Palo Alto often see foreign visitors on their way home
who have spent varying periods of time at the Texas Heart
Institute that, when they leave Houston, they think only
Denton Cooley can do a particular operation but, when
they leave Palo Alto, they think anyone can do it. There
was some muted and sparse laughter but not much recogni-
tion of the point. To continue from the other side of the
table, it is easy to underline the two most important factors
in the entire realm of open heart surgery and cardiopulmo-
nary bypass: (1) water runs downhill and (2) air rises. The
corollary of course is that water seeks its own level, and
we all know bleeding always stops. Once the surgeon has
a good grip on these principles, he or she is ready to
consider the matter of cardiac protection.
There have been many fads in cardiac surgery through the
years, and cardioplegia, by itself a most unattractive word,
is one of them. Almost as many papers have been written
about cardioplegia as use of the internal thoracic artery
for coronary artery bypass grafting. Cardioplegia is in
such routine use that some author recently felt compelled
towrite a paper telling how to do epicardial vascular surgerygery c December 2011
Shumway Presidential Addresswithout cardioplegia. There is almost as much discussion
about ingredients for the cardioplegic solution as there
was in the early days regarding the constituents of the prime
for the heart-lung machine. It came down almost to the use
of vitamins.
In 1958, we became interested in improving the operating
conditions for open heart surgery through elective arrest.
Potassium infusion at the aortic root was even then in vogue
with posthumous recognition being given to the 1883 obser-
vation by Sidney Ringer that potassium will stop the heart.
Results were suboptimal to put it mildly probably because
the component of hypothermia was not present. The heart
would stop certainly, but getting it started again became
the problem. The surgeon could finally see what he was
doing to be sure. All too often the pathologist saw it also.
Certainly, the concentration of potassium was excessive.
Not much thought was required to wonder if hypothermia
might protect against the frequently irreversible nature of
potassium-induced cardiac arrest.
Out of this background developed the concept of local
hypothermia. The heart, unlike the liver or kidneys, is a shell
and not a solid organ. In the definitive experiment of ortho-
topic cardiac transplantation, Dr Richard R. Lower found up
to 7 hours of anoxia were tolerated through simple immer-
sion of the donor heart in physiological saline at 2 to 4C.
Local or topical hypothermia for protection of the anoxic
heart was immediately adopted for clinical use. Having
never administered crystalline or blood cardioplegia, I con-
tinue to be amused by the extravagant claims for it vis-a-vis
improved operative results.
Last month at the annual meeting of the American Col-
lege of Cardiology, I discussed in detail the results of heart
transplantation. The fact that 1-year survival now stands at
80% and 5-year survival at 60% is generally accepted and
appears reproducible in many centers. Today, however,
I would like to direct your attention to the other side of
the picture: A tale of two donors.
Our first little story goes back to 1973, about the time Phi-
lip Caves introduced percutaneous transvenous endomyo-
cardial biopsy for the diagnosis of cardiac rejection. For
reasons that no one could understand, the Stanford Hospital
administrators had entered into an agreement with the Santa
Clara County coroner not to utilize donors who were homi-
cide victims. On the 13th of September, 1973, the Alameda
County district attorney called to offer such a heart donor on
behalf of the victim’s next of kin. Because of the agreement
with the coroner, it was not possible to move the body to
Stanford. Oakland is about 50 air miles from Palo Alto,
so we decided to remove the heart at Highland Hospital—
out of the Santa Clara County coroner’s jurisdiction—and
fly it by helicopter to Stanford. Appropriate plans were
made and the transplant uneventfully completed. A past
president of this society, Dr Paul C. Samson, was in atten-
dance when we removed the donor heart; he said with totalThe Journal of Thoracic and Carwonderment, ‘‘where are you going with that?’’ Perhaps
predictably the defendant’s attorney went to court, and
a jury trial was convened several months later to test the
principle of brain death. The defense contended that the
gunshot victim was doing very well until those surgeons
from Stanford removed his heart. Even our neurosurgeon,
whose reactionary nature was little help in the early days
of heart transplantation, eventually testified concerning
the criteria for brain death. By then the Harvard panel had
already convened, and bases for the diagnosis of brain death
were well publicized. The judge instructed the jury that the
definition of death had been fully respected, and when the
verdict was read, the state of California had its judicial pre-
cedent for the legislature to redefine death in terms of cere-
bral function. The above donor episode inaugurated distant
or remote heart procurement and today less than 5% of all
hearts transplanted at Stanford are from on-site donors. The
necessary legal precedent for statutory recognition of brain
death in the state of California was thus established.
We now move to a second donor story, which has signif-
icant scientific overtones particularly with reference to the
subject of cardiac preservation. Three days before last
Christmas, we were notified of a 4-month-old heart donor
in Fargo, North Dakota. The blood type and weight were
perfect for a 5-month-old recipient dying of endocardial
fibroelastosis. Despite the projected anoxic time of 4 to 5
hours, we decided to go ahead considering the paucity of
infant donors. Dr Edward Stinson accompanied the procure-
ment team since an expert opinion was required concerning
function of the donor heart. A large Lear jet was chartered to
make the 2000 mile trip, and a party of 6 led by Dr Stinson
embarked for the frozen tundra of North Dakota. The team
carried its usual surgical instruments and was clad only in
scrub suits and white coats. The trip to Fargo was unevent-
ful, and the baby donor heart was found to be functionally
satisfactory. After a team from the University of Minnesota
had taken the liver, Stinson removed the heart, placed it in
cold storage, and proceeded quickly to the waiting aircraft.
To the consternation and frustration of all, one of the jet en-
gines would not start, and valuable timewas lost while giant
hair dryers were used in an effort to windmill the disabled
fan jet into action. Nothing happened even when a lighted
broom was thrust into the mouth of the jet engine.
The Stanford contingent deplaned and requested an audi-
ence with the colonel who was in charge of North Dakota’s
Air National Guard. It would be great if a supersonic
military jet could fly the heart to Palo Alto. The colonel
explained that his mission was to protect the north central
United States from a surprise attack over the pole. After
all, the Russians could be coming almost any time. As amat-
ter of fact, you will remember they were in New York last
year for this very meeting as guests of our president, Jim
Malm. They appeared quite peaceful as long as there was
an adequate supply of vodka.diovascular Surgery c Volume 142, Number 6 1297
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Dakota to overrule the colonel and release a military jet for
the trip back to Stanford. It was now 2:15 AM, Central
Standard Time, and the heart had been in extracorporeal res-
idence for 2-and-a-half hours. To make the proverbial long
story short, the governor, George Sinner, gave the order for
an F-4 phantom jet to be available. Incidentally, Governor
Sinner has a brother who is a parish priest in Fargo and,
of course, he bares the unlikely and seemingly contradictory
name of Father Sinner. The F-4 phantom is a 2-passenger
supersonic jet with a range of about 1000 miles. There is
room for the pilot and a navigator or weapons officer but
no other storage that is both temperature and pressure con-
trolled. The navigator would have to hold the ice chest con-
taining the donor heart on his lap. ‘‘Just a minute,’’ replied
the navigator, ‘‘if I have to eject, that ice chest will go right
through me.’’ ‘‘No, thank you,’’ decided the navigator. The
ice chest was then lashed to the seat vacated by the naviga-
tor, and the pilot became a latter-day lone eagle with a brief
but obligatory refueling stop at Ogden, Utah.
Undaunted by all of these problems and complications,
the implant team started the recipient procedure at 4:45 Pa-
cific Standard Time. At 5:30 AM, the new heart was in place,
and the anoxic period had extended to just 15 minutes short
of 8 hours. Richard Lower’s experimental work of 1962 had
reached clinical affirmation. The 5-month-old recipient was
discharged 3 weeks later and continues to do well.
Dr Stinson and his exhausted comrades were stranded in
North Dakota and beginning to resemble the ill-fated Don-
ner party. They finally made it back to San Francisco by
commercial aircraft but not without attracting considerable
suspicion as they changed planes in the Denver airport. For
all I know the Lear jet may still be on an isolated runway in
the frozen north.
So, we see the transplant surgeons and physicians get the
glory, the transplant recipients gain the benefits, but the
transplant donors also have their moments in medical his-
tory. In the two incidents I have cited an important state
lawwas formulated with the advent of distant heart procure-
ment, and a heretofore seemingly unattainable period of
cardiac preservation, nearly 8 hours, was clinically
successful.
Before I go let me introduce several of my colleagues
who are now or who have been at Stanford and have
propelled the art and science of heart transplantation into
a therapeutic reality.1298 The Journal of Thoracic and Cardiovascular SurFirst, Dr Richard R. Lower is the professor and chief of
cardiovascular surgery at the Medical College of Virginia
in Richmond. Long-term survival of the orthotopic heart
transplant was achieved in the laboratory by Dr Lower in
1965 thus providing the necessary background for the
clinical effort.
Dr Edward B. Stinson is the Doelger Professor of Cardio-
vascular Surgery at Stanford. A man for all seasons, immu-
nologist, infectious disease expert, and cardiac surgeon
extraordinaire, Dr Stinson has been in charge of the heart
transplant program at Stanford for the past 15 years.
Dr Randall B. Griepp is professor and chief of cardiovas-
cular surgery at the Mount Sinai Medical Center in New
York City. Dr Griepp is presently on parole having been
charged with committing a successful heart transplant with-
out first gaining permission from the New York City admin-
istrators. Most of us think there is room for a second heart
transplant center in the state of New York since there
must be at least 90 hospitals trying to do heart transplants
in less populated states.
Mr Philip K. Caves was the former Regius Professor of
Cardiovascular Surgery at the University of Glasgow,
Scotland. His untimely death in 1976 deprived him of full
recognition for inventing percutaneous transvenous endo-
myocardial biopsy without which there could be no cyclo-
sporine era.
Dr Margaret E. Billingham is professor of pathology at
Stanford and world authority on matters of the heart. She
and professor Caves made cardiac biopsy the gold standard
for the diagnosis of immunologic events surrounding heart
and heart-lung transplantation.
Dr Philip E. Oyer is professor of cardiovascular surgery
at Stanford, and co-investigator of the successful Novacor
left ventricular assist device. Dr Oyer also holds a PhD in
biochemistry, and his expertise in many related areas has
contributed much to the science of transplantation. Oyer
was instrumental in gaining for Stanford the use of cyclo-
sporine a beginning in December 1980.
Dr Bruce A. Reitz, professor and chief of cardiac surgery
at the Johns Hopkins and who, after conducting meticulous
animal experiments, performed the first successful clinical
transplant of the heart along with both lungs.
If this material, to which you have listened most admira-
bly, does not qualify for the last presidential address, you all
have sufficient tolerance to accept even a xenograft!
Thank you.gery c December 2011
